Evidence map›Paper›PMID 33139647›Full record

ArticleMolecules (Basel, Switzerland)2020

Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.

Liwen Feng, Sébastien Pomel, Perle Latre de Late, Alexandre Taravaud, Philippe M Loiseau, Louis Maes, Fidelis Cho-Ngwa, Christina A Bulman, Chelsea Fischer, Judy A Sakanari and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Structure ofInternational journal of molecular sciences · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Identification of Promising Antifungal Drugs againstJournal of fungi (Basel, Switzerland) · 2021
    Article
  20. Autonomous Non Antioxidant Roles forFrontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Liwen FengUMR 7042 CNRS-Université de Strasbourg-Université Haute-Alsace, Laboratoire d'Innovation Moléculaire et Applications (LIMA), Bioorganic and Medicinal Chemistry Team, European School of Chemistry, Polymers and Materials (ECPM), 25, rue Becquerel, F-67087 Strasbourg, France.ORCID 0000-0002-3372-6161
Sébastien PomelBioCIS, Faculty of Pharmacy, Université Paris-Saclay, CNRS, 92290 Châtenay-Malabry, France.ORCID 0000-0002-9294-3967
Perle Latre de LateINSERM U1016, CNRS UMR 8104, Laboratoire de Biologie Cellulaire Comparative des Apicomplexes, Cochin Institute, Faculté de Medecine, Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France.
Alexandre TaravaudBioCIS, Faculty of Pharmacy, Université Paris-Saclay, CNRS, 92290 Châtenay-Malabry, France.
Philippe M LoiseauBioCIS, Faculty of Pharmacy, Université Paris-Saclay, CNRS, 92290 Châtenay-Malabry, France.ORCID 0000-0002-8542-6793
Louis MaesLaboratory of Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium.ORCID 0000-0002-2324-9509
Fidelis Cho-NgwaBiotechnology Unit, Faculty of Science, University of Buea, Buea P.O. Box 63, Cameroon.
Christina A BulmanDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.
Chelsea FischerDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.
Judy A SakanariDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.
Peter D ZinielDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA.
David L WilliamsDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA.
Elisabeth Davioud-CharvetUMR 7042 CNRS-Université de Strasbourg-Université Haute-Alsace, Laboratoire d'Innovation Moléculaire et Applications (LIMA), Bioorganic and Medicinal Chemistry Team, European School of Chemistry, Polymers and Materials (ECPM), 25, rue Becquerel, F-67087 Strasbourg, France.ORCID 0000-0001-7026-4034
Centre National de la Recherche Scientifique · FRUniversity of California, San Francisco · USRush University Medical Center · USDélégation Paris 5 · FRUniversity of Antwerp · BEUniversity of Buea · CM

Funding

Agence Nationale de la Recherche ANR-11-LABX-0024Bill & Melinda Gates Foundation OPP1017584NIAID Schistosomiasis Resource Center through NIH-NIAID Contract HHSN272201700014I
6 · The paper itself

Abstract

Neglected parasitic diseases remain a major public health issue worldwide, especially in tropical and subtropical areas. Human parasite diversity is very large, ranging from protozoa to worms. In most cases, more effective and new drugs are urgently needed. Previous studies indicated that the gold(I) drug auranofin (Ridaura

Indexed as

AnthelminticsAntineoplastic AgentsAntiprotozoal AgentsAuranofinCoordination ComplexesGoldAnimalsCattleCell Line, TumorDrug EvaluationHelminthiasisHumansNeoplasmsProtozoan InfectionsAnthelminticsAntineoplastic AgentsAntiprotozoal AgentsAuranofinCoordination ComplexesGoldanti-amoebaanticanceranti-helminthanti-leishmanialantiparasiticanti-trypanosomalauranofinglutathionegold(I) complexredox equilibriumthioredoxin

Identifiers

PMID33139647
PMCPMC7663263
OpenAlexW3096564659

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.